Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
3
NMPA:3
Drug Approvals
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20254192
- Approval Date
- May 20, 2025
NMPA
Latamoxef Sodium for Injection
- Product Name
- 注射用拉氧头孢钠
- Approval Number
- 国药准字H20243799
- Approval Date
- May 21, 2024
NMPA
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20233382
- Approval Date
- May 9, 2023
NMPA
Clinical Trials
No trials found
News
No news found